Category: Litigation
-
Abbott Labs stock ‘attractive entry’ amid NEC litigation overhang
•
On Thursday, Piper Sandler began covering Abbott Laboratories (NYSE:NYSE:) stock, assigning an Overweight rating and a $131 price target. The company highlighted the company’s strong performance, but noted that the stock has underperformed year-to-date, largely due to ongoing litigation related to necrotizing enterocolitis (NEC). However, the company believes that the…
-
Top utility trade group joins litigation against new Biden power plant rule (NYSEARCA:XLU)
•
DWalker44/E+ via Getty Images The largest trade group for electric utilities in the United States said this week that it is Join litigation To challenge the Biden administration’s new rules aimed at cutting carbon emissions from new coal and gas-based power plants. Edison Electric Institute said It supports the EPA’s…